- Entry
- $8.07
- Final
- $7.78 -3.6%
- Target
- —
- Score
- -0.36
— ORIGINAL POST ·
🚀 ImmunityBio Reports Continued Execution and Sales Momentum With $113 Million of Preliminary Net Product Revenue—a 700% increase year-over-year
· r/Shortsqueeze
· Jan 15, 2026